Background: A substantial body of evidence is drawing connections between Parkinson's disease (PD) and the phenomena of oxidative stress and mitochondrial dysfunction. Polyphyllin VI (PPVI), an active compound found in Rhizoma Paridis-commonly known as Chonglou (CL) in China, has been identified for its various pharmacological properties, including anti-tumor and anti-inflammatory effects.

Objective: In the present study, an in vitro model of PD was established by treating SH-SY5Y cells with rotenone (ROT), to evaluate the potential neuroprotective effects of polyphyllin VI and its underlying mechanism.

Methods: SH-SY5Y cells were treated with ROT to establish an in vitro model of PD. The effects of polyphyllin VI on cell viability were assessed using the resazurin assay. Cell morphology was examined using a microscope. The YO-PRO-1/PI was used to detect apoptosis. Mito-Tracker Red CMXRos, Mito-Tracker Green, and JC-1 were used to detect the effects of polyphyllin Ⅵ on mitochondrial viability, morphology, and function. Oxidative stress-related marker detection kits were used to identify the effects of polyphyllin VI on oxidative stress. Western blot analysis was employed to investigate the signaling pathways associated with neuroprotection.

Results: PPVI increased ROT-induced SH-SY5Y cell viability and improved ROT-induced cellular morphological changes. PPVI ameliorated ROT-induced oxidative stress status, and attenuated mitochondrial function and morphological changes. PPVI may exert neuroprotective effects through FOXO3α/CREB1/DJ-1-related signaling pathways.

Conclusion: These preliminary findings suggested that PPVI possesses neuroprotective attributes in vitro, and it may be a potential candidate for PD treatment. However, extensive research is necessary to fully understand the mechanisms of PPVI and its effectiveness both in vitro and in vivo.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainres.2024.148824DOI Listing

Publication Analysis

Top Keywords

effects polyphyllin
20
neuroprotective effects
12
sh-sy5y cells
12
oxidative stress
12
vitro model
8
cell viability
8
morphological changes
8
changes ppvi
8
polyphyllin
6
ppvi
6

Similar Publications

Article Synopsis
  • Endometrial carcinoma (EC) often resists hormone therapies like medroxyprogesterone acetate (MPA), necessitating new treatment approaches.
  • This study examines how polyphyllin VII (PPVII) can improve MPA effectiveness by regulating microRNA (miR)-33a-5p in an MPA-resistant Ishikawa cell line.
  • Results showed that combining PPVII with MPA significantly reduced cell viability and increased apoptosis, while PPVII enhanced miR-33a-5p levels, suggesting a potential therapeutic strategy for overcoming hormone resistance in EC.
View Article and Find Full Text PDF

Polyphyllin VI: A promising treatment for prostate cancer bone metastasis.

Int Immunopharmacol

January 2025

Department of Spine Osteopathia, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China. Electronic address:

Prostate cancer, as one of the most prevalent malignant tumors in men, seriously affects the prognosis and survival of patients due to its extremely high rate of bone metastasis. This study investigated the effect of Polyphyllin VI (PPVI) on metastatic bone disease for the first time in prostate cancer, focusing on its impact on osteoclast and tumor cell. In vitro studies utilized TRAP staining, ghost pen cyclic peptide staining, and bone resorption assays to evaluate the differentiation and function of receptor activator of nuclear factor-κB ligand (RANKL) induced and RM-1 conditional medium (CM) induced osteoclasts.

View Article and Find Full Text PDF

Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy.

ACS Nano

November 2024

State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Peking University, Beijing 100142, China.

Article Synopsis
  • * These nanovesicles, loaded with Polyphyllin VI (PPVI) and CDDP, showed high radiochemical purity and stability, and demonstrated improved tumor targeting through micro-PET imaging.
  • * PPVI not only boosted CDDP sensitivity by promoting cell death pathways but also increased immune cell infiltration in tumors, with combined therapy showing a significant regression of NSCLC, offering a promising approach for integrated cancer treatment and monitoring.
View Article and Find Full Text PDF
Article Synopsis
  • Dysregulation of Th17 and Treg cells is linked to brain damage during cerebral ischemia, suggesting that balancing these cell types could aid in post-stroke treatment.
  • Polyphyllin VII (PVII), a compound from the Rhizoma Paridis herb, shows promise in reducing brain damage and improving recovery in a mouse model of stroke by promoting Treg cells and reducing Th1/Th17 cells.
  • PVII operates by inhibiting mTORC1, affecting T cell metabolism and polarization, ultimately leading to a protective effect against cerebral ischemia-reperfusion injury.
View Article and Find Full Text PDF
Article Synopsis
  • Immunotherapy for hepatocellular carcinoma (HCC) is limited due to the low immunogenicity of tumors, but strategies like pyroptosis and photothermal therapy can enhance tumor immunogenic cell death (ICD).
  • Polyphyllin II (PPII) induces pyroptosis in cancer cells and IR780, activated by laser, generates heat to eliminate them; however, both face challenges like low solubility and poor targeting.
  • To improve their effectiveness, PPII and IR780 are co-loaded in targeted PLGA nanoparticles (Apt/PPII/IR780-NPs), allowing for controlled drug release and enhancing anti-tumor immunity, thereby offering a promising new approach for HCC treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!